国际皮肤性病学杂志    2005 31 (1): 38-40   ISSN: 2096-5540  CN: 32-1880/R   核因子кB与皮肤生理、病理及药理 冯华, 郑家润 中国医学科学院、中国协和医科大学皮肤病研究所 南京 210042 收稿日期 2004-02-09  修回日期 null  网络版发布日期 null 参考文献  [1] Dixit V, Mak TW. NF-kappaB signaling. Many roads lead to madrid.Cell, 2002, 111:615-619. [2] Hu Y, Baud V, Oga T, et al. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature, 2001, 410:710-714. [3] Blackwell TS, Christman JW. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol, 1997, 17:3-9. [4] Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest, 2001, 107:135-142. [5] Chen C, Edelstein LC, Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol, 2000, 20:2687-2695. [6] Baldwin AS Jr. Series introduction:the transcription factor NF-kappaB and human disease. J Clin Invest, 2001, 107:3-6. [7] Seitz CS, Deng H, Hinata K, et al. Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res, 2000, 60:4085-4092. [8] Takao J, Yudate T, Das A, et al. Expression of NF-kappaB in epidermis and the relationship between NF-kappaB activation and inhibition of keratinocyte growth. Br J Dermatol, 2003, 148:680-688. [9] Seitz CS, Freiberg RA, Hinata K, et al. NF-kappaB determines localization and features of cell death in epidermis. J Clin Invest, 2000,105:253-260. [10] Danning CL, Illei GG, Hitchon C, et al. Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum, 2000,43:1244-1256. [11] Klement JF, Rice NR, Car BD, et al. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol, 1996, 16:2341-2349. [12] Westergaard M, Henningsen J, Johansen C, et al. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol, 2003, 121:1104-1117. [13] Abeyama K, Eng W, Jester JV, et al. A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest, 2000, 105:1751-1759. [14] Barton D, HogenEsch H, Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol, 2000, 30:2323-2332. [15] Nakamura H, Aoki M, Tamai K, et al. Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Ther, 2002, 9:1221-1229. [16] Santoro A, Majorana A, Bardellini E, et al. NF-kappaB expression in oral and cutaneous lichen planus. J Pathol, 2003, 201:466-472. [17] Ebnet K, Brown KD, Siebenlist UK, et al. Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts.J Immunol, 1997, 158:3285-3292. [18] Becker H, Stengl G, Stein M, et al. Analysis of proteins that interact with the IL-2 regulatory region in patients with rheumatic diseases.Clin Exp Immunol, 1995, 99 :325-330. [19] Burgos P, Metz C, Bull P, et al. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus. J Rheumatol, 2000, 27:116-127. [20] Aradhya S, Woffendin H, Jakins T, et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontincntia pigmenti mutations. Hmn Mol Genet,2001, 10:2171-2179. [21] Smahi A, Courtois G, Rabia SH, et al. The NF-kappaB signalling pathway in human diseases:from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet,2002, 11:2371-2375. [22] Budunova Ⅳ, Perez P, Vaden VR, et al. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene, 1999, 18:7423-7431. [23] Hodgson L, Henderson A J, Dong C. Melanoma cell migration to type Ⅳ collagen requires activation of NF-kappaB. Oncogene, 2003, 22:98-108. [24] Qiu D, Zhao G, Aoki Y, et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purinebox/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem, 1999, 274:13443-13450. [25] Elliott PJ, Zollner TM, Boehncke WH. Proteasome inhibition:a new anti-inflammatory strategy. J Mol Med, 2003, 81:235-245. [26] Schmidt KN, Podda M, Packer L, et al. Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes. J Immunol, 1996, 156:4514-4519. 通讯作者: